Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

VESTAR, FUJISAWA END JOINT AGREEMENT

Aug. 13, 1991

HEMACARE CANCELS SALE OF PLASMA CENTERS

Aug. 13, 1991

START-UP PINS HOPES ON MACROPHAGES

Aug. 12, 1991

FINANCIAL BRIEFS

Aug. 12, 1991

GREENWICH PRIVATE PLACEMENT NETS $3.2 MILLION

Aug. 12, 1991

GENEX EXPLAINS PROTEIN G STABILITY

Aug. 12, 1991

TSI PICKS UP ARGUS LABS

Aug. 12, 1991

U.S. BIO ACQUIRES HEXALEN RIGHTS FOR CANADA

Aug. 12, 1991

JOURNAL SCAN

Aug. 12, 1991

APPOINTMENTS AND ADVANCEMENTS

Aug. 12, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...